Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
2.730
-0.210 (-7.14%)
At close: Jun 27, 2025, 4:00 PM
2.800
+0.070 (2.56%)
After-hours: Jun 27, 2025, 4:04 PM EDT
Lisata Therapeutics Employees
Lisata Therapeutics had 26 employees as of December 31, 2024. The number of employees increased by 1 or 4.00% compared to the previous year.
Employees
26
Change (1Y)
1
Growth (1Y)
4.00%
Revenue / Employee
$38,462
Profits / Employee
-$742,615
Market Cap
23.47M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LSTA News
- 11 days ago - Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development - GlobeNewsWire
- 17 days ago - Lisata Therapeutics to Present at the 2025 BIO International Convention - GlobeNewsWire
- 7 weeks ago - Lisata Therapeutics, Inc. (LSTA) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 7 weeks ago - Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025 - GlobeNewsWire
- 2 months ago - Lisata Therapeutics Announces Research License with Catalent - GlobeNewsWire
- 4 months ago - Lisata Therapeutics to Present at the Investival Showcase USA - GlobeNewsWire
- 4 months ago - Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development - GlobeNewsWire